Huiwen Weng
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Integrating chest CT-derived skeletal muscle index with SARC-F for sarcopenia screening in patients with lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 01, 2026
Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma.
Journal: Journal of medical biochemistry
Published: March 16, 2022
Symptom clusters and their predictors in patients with lung cancer and treated with programmed cell death protein 1 immunotherapy.
Journal: Asia-Pacific journal of oncology nursing
Published: February 23, 2022
miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: October 11, 2021
Development and Validation of a Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 13, 2020
Over-expression of IMPDH2 is associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Journal: American journal of cancer research
Published: June 15, 2018
Over-expression of protein tyrosine phosphatase 4A2 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Journal: Oncotarget
Published: July 07, 2017
High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma.
Journal: Scientific reports
Published: June 28, 2016
Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: August 25, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026